Company Comparison
FibroGen vs BioDefense Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | FibroGen | BioDefense Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | Cambridge |
| Founded | 1993 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Seed |
| Total Funding | — | $11M |
| Valuation | — | — |
What They Build
FibroGen
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
BioDefense Pro
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
Key Investors
FibroGen
BioDefense Pro
No investors listed.
Sector Overlap
Both FibroGen and BioDefense Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.